Cyclacel Pharma (CYCC) Reports Q2 Loss of $0.10

Cyclacel Pharma (NASDAQ: CYCC) reported Q2 EPS of ($0.10), versus ($0.22) reported last year. Revenue for the quarter came in at $356 thousand, versus $296 thousand reported last year.

For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• HP shares slide as tech giant forecasts 2027 PC market slump
• Super Micro Computer rises on AI server market optimism